Grassley probes insurer over ‘penalties’ charged for brand-name drugs

Senator Chuck Grassley

A

fter months of targeting drug makers over their pricing, Senator Chuck Grassley is now probing one of the biggest insurers in the mid-Atlantic region, opening what may become another front in the battle over the cost of prescription medicines.

The lawmaker has asked CareFirst BlueCross BlueShield to explain a complicated policy that he suspects may force patients to overpay for brand-name medications that doctors have specified must be dispensed. Grassley is also concerned that some people may instead feel they have no choice but to opt for lower-cost generic drugs that, in such situations, may not be as effective.

 

Source; https://www.statnews.com/pharmalot/2017/04/18/grassley-probes-insurer-penalties/

Leave a Reply